ImpediMed is an Australian medical device company that makes bioimpedance spectroscopy equipment for clinicians. Its devices measure fluid status and body composition non-invasively, and are used in the assessment and monitoring of lymphoedema, particularly in patients treated for breast cancer. The company supplies hospitals, clinics and healthcare professionals, and its products are used in cancer care and rehabilitation settings. ImpediMed is based in Australia and serves customers in several countries.
Impedimed Ltd trades under the code IPD on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #1716 of 1815 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendWeak
2/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-63.7%
From 52-week high-92.0%
MomentumWeak
21/100
Lagging most stocks on this exchange.
See the numbers →
3-month return0.0%
6-month return-73.3%
12-month, skipping last month-88.1%
Stability (higher is calmer)Weak
3/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)159.6%
Worst drawdown, 1 year (smaller is calmer)-92.0%
LiquidityWeak
46/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.03M AUD
Zero-volume days5.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 0.003 – 0.051Daily closes, split-adjusted
Signals
50-day average0.005
200-day average0.011
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.001
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 0 neutral · 7 bearish
Moving averages (daily)
SMA 10
0.01
Bearish
EMA 10
0.01
Bearish
SMA 20
0.01
Bearish
EMA 20
0.01
Bearish
SMA 50
0.01
Bearish
EMA 50
0.01
Bearish
SMA 100
0.01
Bearish
EMA 100
0.01
Bearish
SMA 200
0.01
Bearish
EMA 200
0.01
Bearish
Oscillators (daily)
RSI (14)
41.33
Neutral
MACD (12, 26)
0.00
Bearish
Momentum (12)
-20.00
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-119.6
Bullish
Pivot points (classic, last session)
S3
0.00
S2
0.00
S1
0.00
Pivot
0.00
R1
0.00
R2
0.01
R3
0.01
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
